Kindeva Drug Delivery announced today that it acquired Summit Biosciences, an intranasal drug-delivery company. Summit, a drug delivery CDMO, brings a track record of innovation in the unit dose nasal spray market. Kindeva believes the acquisition enhances its existing drug delivery capabilities by adding a new platform. This new platform enhances its ability to serve […]
summitbiosciences
Summit Biosciences wins EU nod to manufacture prescription nasal sprays
Summit Biosciences said today that it won a certificate of GMP compliance from the Medicines and Healthcare Products Regulatory Agency on behalf of the European Medicines Agency. The decision comes after a successful inspection of the company’s manufacturing plant in Kentucky. The certificate allows Summit to produce prescription nasal spray products to be exported to […]
